Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy Adults
Clinical trial NCT03771963 · COMPLETED
Trial details
- NCT number
- NCT03771963
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-28
- Primary completion
- 2019-10-14
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.